News from

CAR T Cell Therapy

Reset All Filters
23 Results
Carl June on the boundless potential of CAR T cell therapy
Carl June with a microphone in the Penn Medicine atrium with the celebratory flash mob.

Carl June, at the flash mob celebration of the FDA approval of the CAR T cell therapy he developed, in August 2017.

(Image: Courtesy of Penn Medicine Magazine)

Carl June on the boundless potential of CAR T cell therapy

In a Q & A, June, the Richard W. Vague Professor in Immunotherapy, and Daniel Baker, a fourth-year doctoral student in Penn’s Cell and Molecular Biology department, discuss how the treatment can extend to treating diseases beyond cancer.

From Penn Medicine News

CAR T cell therapy may eliminate tumor cells missed by surgery
Microscopic rendering of t cells targeting a tumor cell with a target symbol.

CAR T cell therapy may eliminate tumor cells missed by surgery

The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells.

From Penn Medicine News